News

Dr Anna Waterhouse delivered the prestigious keynote lecture ‘Biomimicry in blood-contacting medical devices’, presenting the problem of thrombosis, fibrosis and microbe biofouling with blood-contacting medical devices, highlighting that relying on drugs to solve medical device problems results in increased risks of adverse events for patients.

The generosity of HRI UK supporters has enabled the purchase of two cutting-edge microscopes that will help speed our cardiovascular disease research to the next breakthrough.

HRI’s PhD Student Jessica Maclean won Best Oral Presentation at the joint scientific meeting of the Australian Vascular Biology Society (AVBS), the Australia/New Zealand Microcirculation Society (ANZMS) and the Asia/Australia Vascular Biology Meeting (AAVBM).

Congratulations to HRI’s Research Assistant Manisha Patil for winning Best Poster Award by a postgraduate student at the 20^th Scientific Meeting of the Australian & New Zealand Microcirculation Society (ANZMS).

Heart Research Institute is helping to bring together world-leading scientists to solve some of the most pressing issues affecting the hearts of people around the world.

Heart Research Institute scientist David Celermajer has been awarded the inaugural Ruthven Blackburn Medal for his distinguished lifetime contribution to Clinical Research.

HRI spoke to Channel 9 News Health Reporter Gabriella Rogers about how a breakthrough anti-clotting drug is poised to enter Phase 2 clinical trials to improve the quality of life for thousands of stroke sufferers.

Important work to protect people with diabetes from heart disease has been awarded a $2.28m funding boost from the National Health and Medical Research Council (NHMRC).

The Heart Research Institute (HRI) is on the precipice of a significant research breakthrough for stroke treatment which has the potential to be life-changing for stroke survivors and their families, in Australia and around the world.